Sepio Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Sepio Capital's VRTX Position: Q3 2026 in Review
Sepio Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q3 2026, selling an estimated $689K and leaving 7,277 shares worth $3.8M. The position accounts for 0.15% of the portfolio, ranked #71.
Sepio Capital first reported a position in VRTX in Q3 2021 and has held it in 21 quarters since. The position peaked at $5.11M in Q1 2022. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Sepio Capital held 7,277 shares of Vertex Pharmaceuticals worth $3.8M as of Q3 2026.
- Sepio Capital sold 1,346 Vertex Pharmaceuticals shares in Q3 2026, an estimated $689K.
- Vertex Pharmaceuticals made up 0.15% of Sepio Capital's portfolio in Q3 2026, its #71 holding.
- Sepio Capital first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 21 quarters since.
- Sepio Capital's Vertex Pharmaceuticals position peaked at $5.11M in Q1 2022.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Sepio Capital's 13F filing for Q3 2026, filed 22 Oct 2026.